A meta-analysis of comparison between transcranial Doppler ultrasound and transthoracic echocardiography for evaluating PFO-RLS associated with cryptogenic stroke

Yanyan Zhang, Qianqian Xie, Meiqin Yuan2024 · DOI

Introduction

Cryptogenic stroke refers to an ischemic event where the underlying cause remains unidentified after standard diagnostic evaluation. A significant proportion of these cases are linked to Patent Foramen Ovale (PFO) with a Right-to-Left Shunt (RLS). This anatomical defect allows venous emboli to bypass the pulmonary filtration system and enter the systemic circulation, potentially leading to cerebral infarction.

While Contrast Transesophageal Echocardiography (cTEE) is considered the "gold standard" for PFO-RLS diagnosis, its invasive nature and patient discomfort limit its utility as a first-line screening tool. Consequently, non-invasive alternatives such as contrast Transcranial Doppler (cTCD) and contrast Transthoracic Echocardiography (cTTE) are frequently employed. This meta-analysis aims to evaluate and compare the diagnostic performance of cTCD and cTTE to determine the most effective non-invasive approach for clinical practice.

Methods

A systematic review was conducted across major medical databases, including PubMed, Medline, The Cochrane Library, and LILACS, for studies published up to March 2023. The inclusion criteria focused on prospective studies comparing cTTE and cTCD against the cTEE gold standard in patients with cryptogenic stroke.

The quality of the included studies was assessed using the Quality Assessment of Diagnostic Accuracy Studies-2 (QUADAS-2) tool. Statistical synthesis was performed using Revman 5.1 and STATA 14.0 to calculate pooled sensitivity, specificity, and the Area Under the Curve (AUC) for both diagnostic modalities.

Results

The analysis synthesized data from 11 prospective studies conducted in China. Both modalities demonstrated high diagnostic accuracy, but distinct performance profiles emerged:

  • Diagnostic Accuracy (AUC): Both methods showed excellent performance, with cTCD achieving an AUC of 0.98 and cTTE achieving 0.97.
  • Sensitivity: cTCD exhibited superior sensitivity at 97.0% (95% CI: 0.94–0.99). This high sensitivity makes cTCD an exceptional screening tool, as it is highly unlikely to yield false negatives.
  • Specificity: cTTE showed a slightly higher specificity of 92.0% (95% CI: 87.0% to 95.0%), indicating a marginal advantage in confirming the absence of a shunt.

Discussion

The findings suggest that cTCD is the preferred non-invasive screening method due to its near-perfect sensitivity. In the context of cryptogenic stroke, missing a PFO-RLS can lead to missed opportunities for secondary prevention, such as PFO closure. Therefore, the ability of cTCD to reliably identify almost all cases is clinically significant.

However, several limitations must be noted. The included studies were primarily conducted in China, which may affect the generalizability of the results to other global populations with different clinical protocols or genetic backgrounds. Additionally, the exclusion of studies with incomplete data or unavailable full texts may have introduced selection bias, a common hurdle in meta-analytical research.

Conclusion

Both cTCD and cTTE are highly effective non-invasive tools for evaluating PFO-RLS in patients with cryptogenic stroke. However, cTCD's superior sensitivity (97%) and higher overall accuracy (AUC 0.98) position it as the optimal screening choice to ensure that potential cardiac causes of stroke are not overlooked. Future research should focus on the cost-effectiveness of integrating cTCD into standard diagnostic pathways globally.

Summary updated

BibTeX
@misc{zhang2024meta,
  author = {Yanyan Zhang and Qianqian Xie and Meiqin Yuan},
  title = {{A meta-analysis of comparison between transcranial Doppler ultrasound and transthoracic echocardiography for evaluating PFO-RLS associated with cryptogenic stroke}},
  year = {2024},
  doi = {10.37766/inplasy2024.7.0011},
}
Figure